These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Absence of correlation between ABO Rh(D) blood group and neutralizing antibody titers in SARS-CoV-2 convalescent plasma donors. Hirani R; Hoad V; Gosbell IB; Irving DO Transfusion; 2022 Feb; 62(2):292-297. PubMed ID: 34936102 [TBL] [Abstract][Full Text] [Related]
5. ABO blood group does not influence the level of anti-SARS-CoV-2 antibodies in convalescent plasma donors. Žiberna K; Jež M; Jazbec K; Mali P; Potokar UR; Rožman P Transfusion; 2022 Mar; 62(3):556-562. PubMed ID: 35041206 [TBL] [Abstract][Full Text] [Related]
6. Regulatory challenges of convalescent plasma collection during the evolving stages of COVID-19 pandemic in the United States. Hassan S; West KA; Conry-Cantilena K; De Giorgi V Transfusion; 2022 Feb; 62(2):483-492. PubMed ID: 34778974 [No Abstract] [Full Text] [Related]
7. Decrease in serum antibodies to SARS-CoV-2 in convalescent plasma donors over time. Prus K; Alquist CR; Cancelas JA; Oh D Transfusion; 2021 Feb; 61(2):651-654. PubMed ID: 33616966 [No Abstract] [Full Text] [Related]
8. Demographic and Clinical Factors Associated with Reactivity of Anti-SARS-CoV-2 Antibodies in Serbian Convalescent Plasma Donors. Grujić J; Bujandrić N; Budakov-Obradović Z; Dolinaj V; Bogdan D; Savić N; Cabezas-Cruz A; Mijatović D; Simin V; Anđelić N; Banović P Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010301 [TBL] [Abstract][Full Text] [Related]
9. Characteristics and serological patterns of COVID-19 convalescent plasma donors: optimal donors and timing of donation. Li L; Tong X; Chen H; He R; Lv Q; Yang R; Zhao L; Wang J; Xu H; Liu C; Chen G; Chen S; Li C; Qiao J; Yang J; Wu Y; Liu Z Transfusion; 2020 Aug; 60(8):1765-1772. PubMed ID: 32627216 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 neutralizing capacity among blood donors without prior COVID-19 symptomatic history vs. blood donors with prior COVID-19 symptomatic history: A comparative study. Ravula U; Chunchu SR; Mooli S; Naik R; Sarangapati PRR Transfus Clin Biol; 2022 May; 29(2):107-111. PubMed ID: 35167958 [TBL] [Abstract][Full Text] [Related]
12. What is the optimal usage of coronavirus disease 2019 convalescent plasma donations? Focosi D; Tuccori M; Antonelli G; Maggi F Clin Microbiol Infect; 2021 Feb; 27(2):163-165. PubMed ID: 33007479 [No Abstract] [Full Text] [Related]
13. Seroprevalence of SARS-CoV-2 among potential convalescent plasma donors and analysis of their deferral pattern: Experience from tertiary care hospital in western India. Jain R; Mallya MV; Amoncar S; Palyekar S; Adsul HP; Kumar R; Chawla S Transfus Clin Biol; 2022 Feb; 29(1):60-64. PubMed ID: 34302953 [TBL] [Abstract][Full Text] [Related]
14. Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial. Madariaga MLL; Guthmiller JJ; Schrantz S; Jansen MO; Christensen C; Kumar M; Prochaska M; Wool G; Durkin-Celauro A; Oh WH; Trockman L; Vigneswaran J; Keskey R; Shaw DG; Dugan H; Zheng NY; Cobb M; Utset H; Wang J; Stovicek O; Bethel C; Matushek S; Giurcanu M; Beavis KG; di Sabato D; Meltzer D; Ferguson MK; Kress JP; Shanmugarajah K; Matthews JB; Fung JF; Wilson PC; Alverdy JC; Donington JS J Intern Med; 2021 Apr; 289(4):559-573. PubMed ID: 33034095 [TBL] [Abstract][Full Text] [Related]